A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma

Aisha A. H. Al-Jamaei, Ramadugula V. Subramanyam, Marco N. Helder, Tymour Forouzanfar, Erik H. van der Meij, Sayida Al-Jamei, Jan G. A. M. de Visscher

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Tyrosine kinase receptors (TKR) coordinate a variety of pathological processes in head and neck squamous cell carcinoma (HNSCC), and eventually play a role in patient outcomes. In this review, the role of Eph receptors in HNSCC progression and the possibility of targeting these receptors are illustrated. All relevant studies were identified through a comprehensive search of four electronic databases, including PubMed, Scopus, web of science, and Embase till August 2022. EphA2 and EphB4, along with ephrin-B2, were the most extensively studied proteins in this family. However, overexpression of EphB4 and its ligand ephrin-B2 were the only proteins that consistently showed association with a poor outcome, indicating that these proteins might serve as valuable prognostic markers in HNSCC. High expression of EphA3 and EphB4 was found to play a crucial role in radioresistance of HNSCC. EphB4 loss, in particular, was observed to induce an immunosuppression phenotypic HNSCC. Currently, ongoing clinical trials are investigating the benefits of EphB4-ephrin-B2 blockade in combination with standard of care treatment in HNSCC. Further efforts are needed to explore the biological role and behavioral complexity of this family of TKR in HNSCC with great attention to avoid heterogeneity of HNSCC subsites.
Original languageEnglish
JournalOral diseases
Early online date2023
DOIs
Publication statusE-pub ahead of print - 2023

Keywords

  • Eph receptors
  • expression
  • head and neck cancer
  • head and neck squamous cell carcinoma
  • metastasis
  • targeted therapy

Cite this